Social isolation and chronic handling alter endocannabinoid signaling and behavioral reactivity to context in adult rats.
Social deprivation in early life disrupts emotionality and attentional processes in humans. Rearing rats in isolation reproduces some of these abnormalities, which are attenuated by daily handling. However, the neurochemical mechanisms underlying these responses remain poorly understood. We hypothesized that post-weaning social isolation alters the endocannabinoid system, a neuromodulatory system that controls emotional responding. We characterized behavioral consequences of social isolation and evaluated whether handling would reverse social isolation-induced alterations in behavioral reactivity to context and the endocannabinoid system. At weaning, pups were single or group housed and concomitantly handled or not handled daily until adulthood. Rats were tested in emotionality- and attentional-sensitive behavioral assays (open field, elevated plus maze, startle and prepulse inhibition). Cannabinoid receptor densities and endocannabinoid levels were quantified in a separate group of rats. Social isolation negatively altered behavioral responding. Socially-isolated rats that were handled showed less deficits in the open field, elevated plus maze, and prepulse inhibition tests. Social isolation produced site-specific alterations (supraoptic nucleus, ventrolateral thalamus, rostral striatum) in cannabinoid receptor densities compared to group rearing. Handling altered the endocannabinoid system in neural circuitry controlling emotional expression. Handling altered endocannabinoid content (prefrontal and piriform cortices, nucleus accumbens) and cannabinoid receptor densities (lateral globus pallidus, cingulate and piriform cortices, hippocampus) in a region-specific manner. Some effects of social isolation on the endocannabinoid system were moderated by handling. Isolates were unresponsive to handling-induced increases in cannabinoid receptor densities (caudal striatum, anterior thalamus), but were sensitive to handling-induced changes in endocannabinoid content (piriform, prefrontal cortices), compared to group-reared rats. Our findings suggest alterations in the endocannabinoid system may contribute to the abnormal isolate phenotype. Handling modifies the endocannabinoid system and behavioral reactivity to context, but surmounts only some effects of social isolation. These data implicate a pivotal role for the endocannabinoid system in stress adaptation and emotionality-related disturbances.
Sciolino
N R
NR
Neuroscience and Behavior Program, Department of Psychology, University of Georgia, Athens, GA 30622, USA.
Bortolato
M
M
Eisenstein
S A
SA
Fu
J
J
Oveisi
F
F
Hohmann
A G
AG
Piomelli
D
D
D000818:Animals; D001288:Attention; D001522:Behavior, Animal; D001921:Brain / Q000378:metabolism; D063385:Cannabinoid Receptor Modulators / Q000502:physiology*; D004644:Emotions; D063388:Endocannabinoids; D005260:Female; D006234:Handling, Psychological; D008297:Male; D018782:Maze Learning; D051381:Rats; D017207:Rats, Sprague-Dawley; D043882:Receptors, Cannabinoid / Q000378:metabolism; D013216:Reflex, Startle; D015398:Signal Transduction; D012934:Social Isolation
D063385:Cannabinoid Receptor Modulators; D063388:Endocannabinoids; D043882:Receptors, Cannabinoid
J Neurosci. 2009 Aug 12;29(32):9955-60
19675229
J Neurosci. 2002 Sep 15;22(18):7840-3
12223535
J Neural Transm (Vienna). 2008 Dec;115(12):1673-9
18974922
J Neurosci. 1999 Aug 15;19(16):6795-805
10436037
Methods Find Exp Clin Pharmacol. 1984 Aug;6(8):433-6
6541736
Neurosci Lett. 1992 Mar 30;137(2):185-8
1584459
Synapse. 2000 Jul;37(1):71-80
10842353
Eur J Neurosci. 2005 Feb;21(4):1057-69
15787710
Neuropharmacology. 2008 Jan;54(1):108-16
17675104
Trends Pharmacol Sci. 2008 Oct;29(10):493-8
18755516
Chem Phys Lipids. 2002 Dec 31;121(1-2):173-90
12505699
J Neurosci. 2006 Mar 15;26(11):2991-3001
16540577
Physiol Behav. 1988;43(1):13-6
3413245
Acta Psychiatr Scand. 2008 Jun;117(6):420-31
18479318
Psychopharmacology (Berl). 2004 Jan;171(2):148-55
13680076
Nat Med. 2008 Sep;14(9):923-30
18776886
Neurosci Biobehav Rev. 2000 Jun;24(4):417-63
10817843
Mol Neurobiol. 2009 Jun;39(3):178-84
19267225
Nature. 2005 Jun 23;435(7045):1108-12
15973410
Mol Pharmacol. 2007 Dec;72(6):1557-66
17895407
Biol Psychiatry. 1993 Sep 15;34(6):361-72
8218603
Behav Brain Res. 1982 Sep;6(1):93-100
7126327
Proc Natl Acad Sci U S A. 2002 Apr 30;99(9):6370-5
11959912
Neuroscience. 2009 Mar 3;159(1):21-30
19141315
Psychopharmacology (Berl). 2008 Oct;200(3):333-46
18545985
Dev Psychobiol. 2009 May;51(4):333-44
19308959
Exp Neurol. 2003 Oct;183(2):600-9
14552901
Brain Res. 1999 Apr 10;824(2):197-203
10196449
Int J Neuropsychopharmacol. 2009 Jun;12(5):599-614
18789179
Lipids Health Dis. 2003 Aug 19;2:5
12969514
Neurosci Biobehav Rev. 2009 Sep;33(8):1157-67
19747594
Neuropharmacology. 2008 Dec;55(8):1397-404
18809420
Neuropsychopharmacology. 2007 Oct;32(10):2098-107
17299506
Neuropsychopharmacology. 2005 Mar;30(3):508-15
15525997
Biol Psychiatry. 2000 May 15;47(10):864-73
10807959
Neuroendocrinology. 2010;91(2):155-68
19815998
J Neurosci. 1999 Jun 1;19(11):4544-58
10341254
J Neurosci Res. 2005 Oct 15;82(2):264-72
16175569
J Comp Neurol. 2000 Jun 26;422(2):159-71
10842224
Dev Psychobiol. 1977 Mar;10(2):123-32
838157
J Physiol. 2005 Dec 1;569(Pt 2):501-17
16179366
Biol Psychiatry. 2005 Jun 15;57(12):1550-8
15953492
J Neurosci Methods. 1985 Aug;14(3):149-67
2864480
Synapse. 2009 Nov;63(11):941-50
19593824
J Neurosci Methods. 1980 Dec;3(2):129-49
6110810
Neurosci Behav Physiol. 2003 Jan;33(1):13-29
12617300
Psychopharmacology (Berl). 1999 Jun;144(4):311-5
10435402
Psychopharmacology (Berl). 2008 May;198(1):29-36
18084745
Neuropsychopharmacology. 2006 Dec;31(12):2591-9
16710317
Behav Brain Res. 1997 Dec;89(1-2):35-49
9475613
Naunyn Schmiedebergs Arch Pharmacol. 2005 May;371(5):428-33
15995876
Neuroscience. 2010 Apr 14;166(4):1036-42
20096332
Int J Neuropsychopharmacol. 2007 Dec;10(6):727-39
17076936
J Neurosci. 2008 Jul 16;28(29):7284-92
18632932
J Neurochem. 2002 Feb;80(3):448-56
11905991
Int J Neuropsychopharmacol. 2010 Apr;13(3):373-86
19607756
Eur J Neurosci. 2009 May;29(10):1964-78
19453631
Neuropsychopharmacology. 2004 Nov;29(11):2108-14
15354183
Psychopharmacology (Berl). 1998 Oct;139(3):203-9
9784074
Neuron. 2001 Mar;29(3):729-38
11301031
Eur J Pharmacol. 1980 Aug 8;65(4):463-4
7408954
Prog Brain Res. 2008;170:129-36
18655878
Pharmacol Biochem Behav. 2002 Aug;73(1):7-17
12076720
Physiol Behav. 2000 Jan;68(3):389-94
10716550
Psychiatry Res. 1991 Mar;36(3):307-17
1829534
Curr Opin Pharmacol. 2009 Feb;9(1):46-52
19157983
Neurosci Biobehav Rev. 2008 Aug;32(6):1087-102
18423591
Pharmacol Biochem Behav. 1996 May;54(1):21-30
8728535
Neurobiol Dis. 2008 Aug;31(2):159-68
18585920
Clin Exp Pharmacol Physiol. 2003 Apr;30(4):254-61
12680843
Exp Brain Res. 2006 Jul;172(4):556-60
16710682
Physiol Behav. 1997 Aug;62(2):291-7
9251970
Dev Psychopathol. 2005 Spring;17(2):271-301
16761546
Neurosci Lett. 1998 Aug 7;252(1):13-6
9756347
J Comp Neurol. 1977 Mar 15;172(2):247-63
838881
Psychopharmacology (Berl). 2000 Jul;151(1):55-63
10958117
Prog Neuropsychopharmacol Biol Psychiatry. 2004 Mar;28(2):355-60
14751433
Behav Neurosci. 2008 Aug;122(4):849-54
18729638
Psychopharmacology (Berl). 2003 Jan;165(2):128-35
12404071
Brain Res Mol Brain Res. 1993 May;18(3):195-200
8497182
Biol Psychiatry. 2007 Apr 1;61(7):865-72
17125743
Physiol Behav. 1999 Sep;67(3):385-92
10497957
J Neurochem. 2008 Jan;104(1):233-43
17944864
Neurosci Bull. 2007 Nov;23(6):341-7
18064064
Arch Gen Psychiatry. 2000 Aug;57(8):761-8
10920464
J Neurosci. 1991 Feb;11(2):563-83
1992016
Neuroreport. 1999 Jun 3;10(8):1665-9
10501554
Psychopharmacology (Berl). 2009 Jul;204(4):607-16
19259645
Immunobiology. 2010 Aug;215(8):629-46
19616342
Proc Natl Acad Sci U S A. 2000 Jul 5;97(14):8104-9
10884434
Behav Brain Res. 1999 Apr;100(1-2):177-83
10212065
Physiol Behav. 2002 Sep;77(1):55-64
12213502
Physiol Behav. 1982 Jan;28(1):117-24
7079310
Aust N Z J Psychiatry. 2008 May;42(5):357-68
18473254
Behav Brain Res. 1994 Apr 18;61(2):169-73
8037864
Pharmacol Biochem Behav. 2004 Apr;77(4):839-45
15099930
Addict Biol. 2008 Jun;13(2):264-75
18482435
Behav Brain Res. 2001 May;120(2):221-4
11182170
Mol Cell Neurosci. 2000 Jun;15(6):510-21
10860578
Brain Res. 2007 Apr 13;1141:37-47
17300761
Neuroscience. 2008 Mar 3;152(1):265-72
18082330
Neuroscience. 2002;110(4):755-64
11934482
Neuropharmacology. 2008 Dec;55(7):1183-90
18708079
Neuropharmacology. 2009;56 Suppl 1:226-34
18691604
Neuropharmacology. 2008 Apr;54(5):815-23
18262573
Eur J Pharmacol. 1990 Nov 20;191(1):111-4
2092998
Neuroscience. 2001;103(1):9-15
11311783
J Neurosci. 2003 Aug 13;23(19):7281-7
12917361
Psychopharmacology (Berl). 2004 Sep;175(2):220-4
15088080
Hippocampus. 2009 Jul;19(7):623-32
19115376
J Neurosci. 2006 May 24;26(21):5628-37
16723519
Brain Res. 2003 Sep 5;983(1-2):128-36
12914973
Synapse. 2009 Jun;63(6):476-83
19217027
Behav Brain Res. 1996 Feb;75(1-2):27-32
8800657
J Chromatogr B Analyt Technol Biomed Life Sci. 2009 Sep 15;877(26):2755-67
19171504
Arch Gen Psychiatry. 2000 Jul;57(7):637-48
10891034
Braz J Med Biol Res. 2005 Nov;38(11):1691-6
16258640
Int J Neuropsychopharmacol. 2007 Oct;10(5):595-607
17134528
Brain Res. 1999 Mar 20;822(1-2):17-25
10082879
Eur J Neurosci. 2006 Jun;23(12):3319-27
16820021
Eur Arch Psychiatry Clin Neurosci. 2009 Oct;259(7):371-82
19588184